This topic contains a solution. Click here to go to the answer

Author Question: Which statement best explains why structural changes occur within the brains of people with ... (Read 62 times)

s.tung

  • Hero Member
  • *****
  • Posts: 577
Which statement best explains why structural changes occur within the brains of people with Alzheimer's disease?
 
  1. Increased acetylcholine levels
  2. Increases in blood pressure and cholesterol levels
  3. Chronic inflammation and oxidative cellular damage
  4. Cerebral bleeding and associated hypoxia

Question 2

The client receives prednisone as treatment for his inflammatory disease. He has experienced great relief and asks the nurse if he can just keep taking this medication. What is the best response by the nurse?
 
  1. No, because this medication has serious adverse effects.
  2. No, your doctor said the best treatment for your illness is to alternate medications.
  3. No, your body would get used to it and it would lose its effectiveness.
  4. No, because your illness is in remission and you don't need medication now.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ladyjames123

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

3
Rationale 1: There is no increase of acetylcholine levels.
Rationale 2: Blood pressure and cholesterol levels are not implicated.
Rationale 3: Alzheimer's disease is characterized by amyloid plaques and neurofibrillary tangles that most likely occur from chronic inflammation or oxidative cellular damage.
Rationale 4: Cerebral bleeding and associated hypoxia are not implicated.
Global Rationale: Alzheimer's disease is characterized by amyloid plaques and neurofibrillary tangles that most likely occur from chronic inflammation or oxidative cellular damage. There is no increase of acetylcholine levels.
Blood pressure and cholesterol levels are not implicated. Cerebral bleeding and associated hypoxia are not implicated.

Answer to Question 2

1
Rationale 1: Systemic glucocorticoids are reserved for the short-term treatment of severe disease because of potentially serious adverse effects.
Rationale 2: Medications are alternated due to the serious effects of glucocorticoids, not because this is the best treatment for the illness.
Rationale 3: The body does not get used to systemic glucocorticoids.
Rationale 4: There is no evidence that the client's illness is in remission.
Global Rationale: Systemic glucocorticoids are reserved for the short-term treatment of severe disease because of potentially serious adverse effects. Medications are alternated due to the serious effects of glucocorticoids, not because this is the best treatment for the illness. The body does not get used to systemic glucocorticoids. There is no evidence that the client's illness is in remission.




s.tung

  • Member
  • Posts: 577
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


tandmlomax84

  • Member
  • Posts: 323
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library